Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives.
Open Access
- 9 July 1996
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (14), 7295-7299
- https://doi.org/10.1073/pnas.93.14.7295
Abstract
So324 is a 2',3'-dideoxy-2',3'-didehydrothymidine-5'-monophosphate (d4T-MP) prodrug containing at the phosphate moiety a phenyl group and the methylester of alanine linked to the phosphate through a phosphoramidate linkage. So324 has anti-HIV activity in human CEM, MT4, and monocyte/macrophage cells that is superior to that of d4T. In contrast to d4T, So324 is also able to inhibit HIV replication in thymidine kinase-deficient CEM cells. After uptake of So324 by intact human lymphocytes, d4T-MP is released and subsequently converted intracellularly to d4T-TP. In addition, accumulation of substantial amounts of a novel d4T derivative has been found. This d4T metabolite has been characterized as alaninyl d4T-MP. The latter metabolite accumulates at approximately 13- to 200-fold higher levels than d4T-TP depending the experimental conditions. Alaninyl d4T-MP should be considered as an intra- and/or extracellular depot form of d4T and/or d4T-MP. These findings may explain the superior anti-retroviral activity of So324 over d4T in cell culture.Keywords
This publication has 13 references indexed in Scilit:
- Aryl Phosphoramidate Derivatives of d4T Have Improved Anti-HIV Efficacy in Tissue Culture and May Act by the Generation of a Novel Intracellular MetaboliteJournal of Medicinal Chemistry, 1996
- Certain phosphoramidate derivatives of dideoxy uridine (ddU) are active against HIV and successfully by-pass thymidine kinaseFEBS Letters, 1994
- Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytesBiochemical and Biophysical Research Communications, 1991
- POTENT DNA CHAIN TERMINATION ACTIVITY AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE BY 2',3'-DIDEOXYURIDINE-5'-TRIPHOSPHATE1990
- PHOSPHORYLATION OF 2',3'-DIDEOXYINOSINE BY CYTOSOLIC 5'-NUCLEOTIDASE OF HUMAN LYMPHOID-CELLS1989
- DIFFERENTIAL PATTERNS OF INTRACELLULAR METABOLISM OF 2',3'-DIDEHYDRO-2',3'-DIDEOXYTHYMIDINE AND 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE, 2 POTENT ANTI-HUMAN IMMUNODEFICIENCY VIRUS COMPOUNDS1989
- FACTORS DETERMINING THE ACTIVITY OF 2',3'-DIDEOXYNUCLEOSIDES IN SUPPRESSING HUMAN IMMUNODEFICIENCY VIRUS INVITRO1988
- Anti-retrovirus activity of 3′-fluoro- and 3′-azido-substituted pyrimidine 2′,3′-dideoxynucleoside analoguesBiochemical Pharmacology, 1988
- Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivityBiochemical Pharmacology, 1987
- THE ANTI-HTLV-III (ANTI-HIV) AND CYTOTOXIC ACTIVITY OF 2',3'-DIDEHYDRO-2',3'-DIDEOXYRIBONUCLEOSIDES - A COMPARISON WITH THEIR PARENTAL 2',3'-DIDEOXYRIBONUCLEOSIDES1987